Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Caspase-4 Colorimetric Assay Kit for Pyroptosis
2026-08-19
The Caspase-4 Colorimetric Assay Kit converts LEVD-pNA cleavage into a practical 400–405 nm readout for studying inflammation, pyroptosis, and treatment response. This guide connects the assay to ER-stress research while emphasizing controls that distinguish caspase-4 activity from broader cell-death effects.
-
2D and 3D Radiosensitizer Screening in Lung Cancer
2026-08-19
This 2025 Acta Oncologica study systematically compared DNA-PKcs, ATR, PARP, and IAP inhibitors as radiation sensitizers in matched two-dimensional and extracellular-matrix-based three-dimensional lung cancer models. DNA-PKcs and ATR inhibition produced the most consistent effects, while 3D cultures added matrix-dependent information that can improve preclinical prioritization without making 2D assays obsolete.
-
Thiazovivin (A5506): Practical ROCK Inhibitor Guide
2026-08-18
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming during induced pluripotent stem cell generation and to improve human embryonic stem cell survival after trypsinization. This guide covers product-specific preparation, storage, controls, and troubleshooting; it is for research use only and does not establish diagnostic, therapeutic, or clinical use.
-
Genotyping as a Control Point in Macrophage Translation
2026-08-18
Reliable genotype confirmation is more than a colony-management task: it is a prerequisite for interpreting lineage, reporter, and conditional knockout experiments. This thought-leadership article connects macrophage plasticity in liver metastasis with practical strategies for faster, more controlled mouse genotyping workflows.
-
Olaparib Workflows for DNA Damage Research
2026-08-17
Build reproducible Olaparib and AZD2281 experiments around homologous recombination status, BAP1 biology, and orthogonal DNA damage readouts. This practical guide covers stock handling, combination designs, tumor radiosensitization studies, and troubleshooting for translational cancer research.
-
NADH Workflows for Redox and Mitochondrial Research
2026-08-17
Build more informative redox experiments with NADH, from controlled cell-culture supplementation to LC-MS/MS measurement of the NADH/NAD⁺ ratio. This practical guide connects mitochondrial electron transport chain research with Leigh syndrome models and photocatalytic cancer therapy while emphasizing stability, normalization, and interpretation limits.
-
Z-YVAD-FMK: Practical Caspase-1 Inhibitor Workflows
2026-08-16
Z-YVAD-FMK is a cell-permeable, irreversible caspase-1 inhibitor for separating inflammasome-driven pyroptosis from apoptosis and nonspecific cytotoxicity. This guide covers assay design, dosing logic, gasdermin-focused readouts, and troubleshooting for inflammatory cell-death and cancer research.
-
Acridine Orange hydrochloride: Practical Guide
2026-08-15
Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric workflows. It should be used in validated assay conditions with fresh solutions; the product dossier does not establish universal working concentrations, fixation conditions, or standalone diagnostic interpretation.
-
Cyclophilin A and Cyclosporine Resistance
2026-08-14
The reference study used Ppia-deficient mice and immune-cell assays to show that cyclophilin A is the principal intracellular mediator of cyclosporine-induced immunosuppression. Its cellular, reconstitution, and allogeneic-challenge experiments provide a rigorous framework for separating drug-binding partners from the protein required for calcineurin pathway inhibition.
-
Sinapine Targets PLCβ3 EF Hands in CVD
2026-08-14
A 2024 Phytomedicine study identifies sinapine as a chemical blocker of the Gαq–PLCβ3 interaction, acting through the PLCβ3 EF-hand region and Asn-260 rather than by broadly inhibiting Gαq. Using chemical proteomics, biochemical assays, and aldosteronism and hypertension models, the authors connect this protein–protein interaction mechanism with improved cardiovascular phenotypes.
-
Z-WEHD-FMK in Pyroptosis and Caspase Research
2026-08-13
Z-WEHD-FMK enables cell-based dissection of inflammatory caspase activity across cancer and host–pathogen models. Its irreversible, cell-permeable action is especially useful for connecting caspase inhibition with pyroptosis, Golgi remodeling, and microbial proliferation.
-
L-Alanyl-L-Glutamine: Practical Lab Workflow
2026-08-13
L-Alanyl-L-Glutamine (SKU B8228) provides a water-soluble L-Ala-L-Gln dipeptide for controlled nutritional, epithelial, and gastrointestinal model workflows where glutamine delivery and solution handling are important. The product dossier supports formulation and handling decisions, but no directly matched paper evidence is available here for a universal dose, exposure time, clinical outcome, or disease-specific application.
-
Gold(I) Phosphine Complex Drives ROS-Mediated Apoptosis
2026-08-12
A 2025 Molecular and Cellular Biochemistry study identifies a gold(I) phosphine complex that targets thioredoxin reductase, elevates reactive oxygen species, disrupts mitochondrial function, and induces apoptosis in prostate cancer models. Compound 5 showed stronger antitumor activity than cisplatin and auranofin in the reported assays and also suppressed xenograft growth without severe observed toxicity, supporting further investigation of redox-directed cancer therapeutics.
-
CRL3ARMC5 and Integrator Control Early RNA Pol II
2026-08-12
Cacioppo et al. identify CRL3ARMC5-mediated ubiquitylation and Integrator phosphatase activity as parallel quality-control pathways that regulate RNA polymerase II before productive elongation. The study shows that these mechanisms control both RNA Pol II abundance and transcriptional competence, revealing why excess or defective complexes are normally prevented from entering gene bodies.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-11
The 2025 reference study shows that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike protein binding to AXL, with sequence truncation and tyrosine modification influencing activity. Its antibody-based binding experiments connect renin-angiotensin system biology with viral receptor interactions while highlighting the need for cell-based and physiological validation.